BioPorto

Pre-Annual General Meeting Information • Aug 15, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

August 15, 2019

Announcement no. 16

BioPorto A/S - Extraordinary General Meeting

Today, BioPorto A/S held an extraordinary general meeting where Christopher Lindop and Michael Singer were elected as members of the Board of Directors. There were no other changes to the composition of the Board of Directors.

Hellerup, August 15, 2019

BioPorto A/S

The Board of Directors

For further information, please contact:

Peter Mørch Eriksen, CEO

Ole Larsen, CFO

Telephone +45 4529 0000, e-mail investor@bioporto.com

About BioPorto

BioPorto is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. BioPorto has its headquarters in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange

Attachment

• 16 Announcement 2019 08 15